Moleculin Biotech (MBRX) Q3 2024 Earnings
MBRX·Reported November 11, 2024·Before market open
Diluted EPS came in at $-2.85, missed the $-2.44 consensus by $0.41.
Diluted EPS
$-2.85missed by $0.41
Consensus: $-2.44
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Moleculin Biotech's Q3 2024 earnings report.
Moleculin Biotech (MBRX) reported Q3 2024 earnings on November 11, 2024 before market open.
Moleculin Biotech reported diluted EPS of $-2.85 for Q3 2024.
EPS missed the consensus estimate of $-2.44 by $0.41.
You can read the 10-Q periodic report (0001437749-24-034236) directly on SEC EDGAR. The filing index links above go to sec.gov.